323 related articles for article (PubMed ID: 10960429)
1. The management of Helicobacter pylori infection in primary care: a systematic review of the literature.
Childs S; Roberts A; Meineche-Schmidt V; de Wit N; Rubin G
Fam Pract; 2000 Aug; 17 Suppl 2():S6-11. PubMed ID: 10960429
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
Ladabaum U; Chey WD; Scheiman JM; Fendrick AM
Aliment Pharmacol Ther; 2002 Aug; 16(8):1491-501. PubMed ID: 12182749
[TBL] [Abstract][Full Text] [Related]
3. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
4. Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review.
Huang JQ; Zheng GF; Hunt RH; Wong WM; Lam SK; Karlberg J; Wong BC
World J Gastroenterol; 2005 May; 11(18):2726-32. PubMed ID: 15884111
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.
Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B
Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori and dyspepsia: physicians' attitudes, clinical practice, and prescribing habits.
O'Connor HJ
Aliment Pharmacol Ther; 2002 Mar; 16(3):487-96. PubMed ID: 11876702
[TBL] [Abstract][Full Text] [Related]
8. The use of consensus to develop guidelines for the management of Helicobacter pylori infection in primary care. European Society for Primary Care Gastroenterology.
Rubin G; Meineche-Schmidt V; Roberts A; de Wit N
Fam Pract; 2000 Aug; 17 Suppl 2():S21-6. PubMed ID: 10960431
[TBL] [Abstract][Full Text] [Related]
9. Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer.
McColl KE; el-Nujumi A; Murray LS; el-Omar EM; Dickson A; Kelman AW; Hilditch TE
Gut; 1998 May; 42(5):618-22. PubMed ID: 9659153
[TBL] [Abstract][Full Text] [Related]
10. Relevance of underlying disease and bacterial vacA and cagA status on the efficacy of Helicobacter pylori eradication.
Rudi J; Reuther S; Sieg A; Hoerner M; Stremmel W
Digestion; 2002; 65(1):11-5. PubMed ID: 11961337
[TBL] [Abstract][Full Text] [Related]
11. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences.
Ofman JJ; Etchason J; Fullerton S; Kahn KL; Soll AH
Ann Intern Med; 1997 Feb; 126(4):280-91. PubMed ID: 9036800
[TBL] [Abstract][Full Text] [Related]
12. Management of Helicobacter pylori infection.
Costa F; D'Elios MM
Expert Rev Anti Infect Ther; 2010 Aug; 8(8):887-92. PubMed ID: 20695744
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
Satoh K; Yoshino J; Akamatsu T; Itoh T; Kato M; Kamada T; Takagi A; Chiba T; Nomura S; Mizokami Y; Murakami K; Sakamoto C; Hiraishi H; Ichinose M; Uemura N; Goto H; Joh T; Miwa H; Sugano K; Shimosegawa T
J Gastroenterol; 2016 Mar; 51(3):177-94. PubMed ID: 26879862
[TBL] [Abstract][Full Text] [Related]
14. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.
Ford AC; Delaney BC; Forman D; Moayyedi P
Am J Gastroenterol; 2004 Sep; 99(9):1833-55. PubMed ID: 15330927
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori and non-malignant diseases.
Rokkas T; Simsek I; Ladas S
Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
[TBL] [Abstract][Full Text] [Related]
16. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.
Sonnenberg A
Am J Gastroenterol; 1996 Sep; 91(9):1773-7. PubMed ID: 8792696
[TBL] [Abstract][Full Text] [Related]
17. Critical issues in the pathophysiology and management of peptic ulcer disease.
Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166
[TBL] [Abstract][Full Text] [Related]
18. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
19. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.
Malfertheiner P; Megraud F; O'Morain C; Bazzoli F; El-Omar E; Graham D; Hunt R; Rokkas T; Vakil N; Kuipers EJ
Gut; 2007 Jun; 56(6):772-81. PubMed ID: 17170018
[TBL] [Abstract][Full Text] [Related]
20. Are dyspepsia management guidelines coherent with primary care practice?
Cardin F; Zorzi M; Furlanetto A; Guerra C; Bandini F; Polito D; Bano F; Grion AM; Toffanin R
Scand J Gastroenterol; 2002 Nov; 37(11):1269-75. PubMed ID: 12465724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
